Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion type Assertion NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_head.
- NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion description "[Here, we show that in clinical samples bladder tumors with intense expression of stem cell marker Oct-3/4 (also known as POU5F1) are associated with further disease progression, greater metastasis, and shorter cancer-related survival compared with those with moderate and low expressions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_provenance.
- NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion evidence source_evidence_literature NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_provenance.
- NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion SIO_000772 18676852 NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_provenance.
- NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion wasDerivedFrom befree-2016 NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_provenance.
- NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_assertion wasGeneratedBy ECO_0000203 NP685813.RAjg7-BMAEhGbbd7ROEgzbnBvDiyXCC7qc2hL2ysgXsDw130_provenance.